3.8 Article Book Chapter

Stem Cells, Retinal Ganglion Cells and Glaucoma

Journal

Publisher

KARGER
DOI: 10.1159/000358409

Keywords

-

Funding

  1. NEI NIH HHS [R21 EY023812, R21 EY017155, R21 EY019737, R01 EY023754, T32 EY007143, R43 EY023495, P30 EY001765, R01 EY009769, R21 EY022769] Funding Source: Medline
  2. NIGMS NIH HHS [T32 GM007445] Funding Source: Medline

Ask authors/readers for more resources

Retinal ganglion cells (RGCs) represent an essential neuronal cell type for vision. These cells receive inputs from light-sensing photoreceptors via retinal interneurons and then relay these signals to the brain for further processing. RGC diseases that result in cell death, e. g. glaucoma, often lead to permanent damage since mammalian nerves do not regenerate. Stem cell differentiation can generate cells needed for replacement or can be used to generate cells capable of secreting protective factors to promote survival. In addition, stem cell-derived cells can be used in drug screening research. Here, we discuss the current state of stem cell research potential for interference in glaucoma and other optic nerve diseases with a focus on stem cell differentiation to RGCs. (C) 2014 S. Karger AG, Basel

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available